Joji Kitayama

Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial

Hironori Ishigami, Yoshiyuki Fujiwara, Ryoji Fukushima et al. · Journal of Clinical Oncology · 2018 · 347 citations

Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis

Hironori Ishigami, Joji Kitayama, Shoichi Kaisaki et al. · Annals of Oncology · 2009 · 231 citations · Full text

Surgical Oncology, Intraperitoneal Paclitaxel, Gastrointestinal Oncology +8

Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.

Dai Shida, Joji Kitayama, Hironori Yamaguchi et al. · PubMed · 2003 · 214 citations

Pathology, Cancer Biology, Tumor Biology +16

Differential regulation of beta 1 and beta 2 integrin avidity by chemoattractants in eosinophils.

Christian Weber, Joji Kitayama, T. Springer · Proceedings of the National Academy of Sciences · 1996 · 190 citations · Full text

Cell Adhesion, Immunology, Cytoskeleton +22

Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination

Shigenobu Emoto, Hironori Ishigami, Hiroharu Yamashita et al. · Gastric Cancer · 2011 · 178 citations

Tumor Biology, Gastrointestinal Oncology, Medicine +9